Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ginkgo Bioworks Hldgs Inc (NY: DNA ) 0.2215 -0.0331 (-13.00%) Official Closing Price Updated: 7:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ginkgo Bioworks Hldgs Inc < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021 October 13, 2021 Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ: Via Benzinga Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy October 13, 2021 If the latest short-seller attack on Ginkgo Bioworks has you nervous about synthetic biology, consider the industry leader. Via The Motley Fool ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm October 12, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After Last Week’s “Scam” Accusation October 12, 2021 Ginkgo Bioworks (DNA) stock is doing well on Tuesday as it recovers with new coverage from an analyst with a bull stance. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021 October 12, 2021 Upgrades For Callaway Golf Co (NYSE:ELY), Compass ... Via Benzinga 46 Biggest Movers From Yesterday October 12, 2021 Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... Via Benzinga Exposures Product Safety GINKGO BIOWORKS INVESTOR ALERT October 11, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm October 11, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal 28 Stocks Moving In Monday's Mid-Day Session October 11, 2021 Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical... Via Benzinga Exposures Product Safety Cathie Wood's Ark Invest Piles Up Another $15.8M In Gingko On Dip Amid Short-Seller Allegations October 11, 2021 Cathie Wood-led Ark Invest on Friday snapped up more shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the dip. The popular money manager’s investment firm snapped up 1.... Via Benzinga GINKGO BIOWORKS SHAREHOLDER NOTICE October 10, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GINKGO BIOWORKS SHAREHOLDER ALERT October 08, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm October 09, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal GINKGO ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Ginkgo Stockholders and Encourages Investors to Contact the Firm October 07, 2021 From Bragar Eagel & Squire, P.C. Via Business Wire ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm October 07, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal GINKGO BIOWORKS INVESTOR ALERT October 07, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire DNA Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Investors October 07, 2021 From Kessler Topaz Meltzer & Check, LLP Via Business Wire ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm October 07, 2021 From The Schall Law Firm Via Business Wire 40 Biggest Movers From Yesterday October 07, 2021 Gainers Volcon, Inc. (NASDAQ: VLCN) shares jumped 97.5% to settle at $10.86 on Wednesday as the company priced its IPO at $5.50 per share. Voyager Therapeutics, Inc. (NASDAQ:... Via Benzinga Topics Initial Public Offering Exposures Securities Market Cathie Wood Sells $49.4M In Tesla And Buys $87.5M In Ginkgo Bioworks On Dip As Stock Becomes Target Of Short Sellers October 06, 2021 Cathie Wood-led Ark Invest on Wednesday snapped up shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the day the synthetic biology company stock was hit hard by two back-to-... Via Benzinga Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors October 06, 2021 From Glancy Prongay & Murray LLP Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors October 06, 2021 From Cruz The Law Offices of Frank R. Cruz Via Business Wire INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm October 06, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors October 06, 2021 From Law Offices of Howard G. Smith Via Business Wire GINKGO BIOWORKS INVESTOR ALERT - Investors Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C. October 06, 2021 PHILADELPHIA, PA / ACCESSWIRE / October 6, 2021 / Kehoe Law Firm, P.C. is investigating whether Ginkgo Bioworks ("Ginkgo" or the "Company") (NYSE:DNA) violated federal securities laws. Ginkgo investors... From Kehoe Law Firm, P.C. Via AccessWire Topics Fraud Exposures Legal DNA Stock: 7 Things to Know About the Short Report Hammering Ginkgo Bioworks October 06, 2021 Today, Ginko Bioworks and DNA stock are firmly in the sights of short-sellers as various claims are made about an elaborate fraud underway. Via InvestorPlace Topics Fraud Exposures Legal INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm October 06, 2021 From The Schall Law Firm Via Business Wire Ginkgo Bioworks Stock Drops 20% After Short Sellers Call Company A 'Colossal Scam' October 06, 2021 Shares of synthetic biology company Ginkgo Bioworks Holdings Inc (NYSE: Via Benzinga 26 Stocks Moving In Wednesday's Mid-Day Session October 06, 2021 Gainers Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option agreement with Pfizer for capsids generated from... Via Benzinga Here's Why This Cathie Wood Stock Is Crashing Today October 06, 2021 Scorpion Capital is shooting some venom at a new target today. Via The Motley Fool < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.